Morningstar

Virtus KAR Health Sciences Inst HLHIX

Morningstar Medalist Rating
Medalist Rating as of | See Virtus Investment Hub
  • NAV / 1-Day Return 31.37  /  −0.29 %
  • Total Assets 140.1 Mil
  • Adj. Expense Ratio
    1.120%
  • Expense Ratio 1.120%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.00
  • Turnover 6%

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:20 PM GMT+0

Morningstar’s Analysis HLHIX

Will HLHIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable HLHIX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the HLHIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of HLHIX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Increased confidence in Virtus KAR Health Sciences Inst's prospects relative to its Morningstar Category peers results in an upgrade in this strategy's Morningstar Medalist Rating to Neutral from Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HLHIX

More HLHIX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 51.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

13.29 19.4 Mil
Healthcare

UnitedHealth Group Inc

4.84 7.1 Mil
Healthcare

AbbVie Inc

4.82 7.0 Mil
Healthcare

Vertex Pharmaceuticals Inc

4.29 6.3 Mil
Healthcare

Merck & Co Inc

4.27 6.2 Mil
Healthcare

Edwards Lifesciences Corp

4.07 5.9 Mil
Healthcare

McKesson Corp

4.06 5.9 Mil
Healthcare

The Cooper Companies Inc

4.01 5.8 Mil
Healthcare

IDEXX Laboratories Inc

3.90 5.7 Mil
Healthcare

Danaher Corp

3.82 5.6 Mil
Healthcare

Sponsor Center